NeurosciencebioRxivPreprint
Targeted proteomics of postmortem human brain reveals neurobiologic heterogeneity in Alzheimer's disease using NULISA technology
Sara Rose Dunlop, Sarah Lincoln, Zhongwei Peng…·Melissa Erin Murray
This study uses targeted proteomics to identify protein expression differences in Alzheimer's disease cases with varying clinical and neuropathological features.
DOI 10.64898/2026.07.01.735558